Evusheld offers vulnerable Americans protection from COVID. But getting it has been complicated.

May 24, 2022
Scarcity and a lack of outreach has left millions of immunocompromised Americans without access to the treatment.
The Biden administration ordered 1.7 million doses of Evusheld, but around three-quarters of those may have gone unused, according to some estimates.
Jonathan Nackstrand/AFP via Getty Images

Simmering tensions over EU vaccine distribution threaten to boil over

Jan 27, 2021
The 27-nation bloc is battling with manufacturers over its spot in the priority list for receiving COVID vaccines.
Joel Saget/AFP via Getty Images

The cost of "vaccine nationalism": $9 trillion

Jan 26, 2021
With shortfalls in vaccine supplies, countries across the world are concerned about getting their fair share of doses.
A health worker carries syringes to administer Pfizer COVID-19 vaccines at the opening of a new vaccination site at Corsi Houses in Harlem, New York, on Jan. 15.
Kena Betancur/AFP via Getty Images

AstraZeneca vaccine is third to show promising data in unprecedented hurry-up race

Nov 23, 2020
The COVID-19 vaccine is being produced so quickly due to a combination of factors involving the research community, government, industry and the public.
A volunteer receives a COVID-19 vaccination at the Research Centers of America in Hollywood, Florida.
Chandan Khanna/AFP via Getty Images

Need some Econ 101?

Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.